Growth Metrics

Zymeworks (ZYME) Non-Current Deferred Tax Liability (2021 - 2026)

Zymeworks recorded quarterly Non-Current Deferred Tax Liability of $3.8 million in Q1 2026, down 36.51% quarter-over-quarter from $6.0 million in Q4 2025, and down 20.52% year-over-year from $4.8 million in Q1 2025.

Zymeworks' Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability fell 20.52% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 20.52% YoY), while the FY2025 annual figure was $6.0 million, up 26.61% from the prior year.
  • Non-Current Deferred Tax Liability came in at $3.8 million for Q1 2026 at Zymeworks, down from $6.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.0 million in Q4 2025 to a low of $1.6 million in Q3 2022.
  • A 5-year average of $3.4 million and a median of $3.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability tumbled 87.32% in 2022 and surged 84.56% in 2023, its largest moves.
  • Zymeworks' Non-Current Deferred Tax Liability stood at $1.8 million in 2022, then soared by 84.56% to $3.3 million in 2023, then jumped by 44.27% to $4.8 million in 2024, then gained by 26.61% to $6.0 million in 2025, then sank by 36.51% to $3.8 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $3.8 million, $6.0 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Zymeworks 1.84 Bn 1.47 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.83 Mn
Mar 31, 2026 3.83 Mn
Dec 31, 2025 6.03 Mn
Dec 31, 2025 6.03 Mn
Sep 30, 2025 4.77 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 4.85 Mn
Jun 30, 2025 4.85 Mn
Mar 31, 2025 4.82 Mn
Mar 31, 2025 4.82 Mn
Dec 31, 2024 4.76 Mn
Dec 31, 2024 4.76 Mn
Sep 30, 2024 3.46 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 3.40 Mn
Jun 30, 2024 3.40 Mn
Mar 31, 2024 3.35 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 3.30 Mn
Dec 31, 2023 3.30 Mn
Sep 30, 2023 1.97 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.92 Mn
Jun 30, 2023 1.92 Mn
Mar 31, 2023 1.86 Mn
Mar 31, 2023 1.86 Mn
Dec 31, 2022 1.79 Mn
Dec 31, 2022 1.79 Mn
Sep 30, 2022 1.59 Mn
Sep 30, 2022 1.59 Mn
Dec 31, 2021 14.10 Mn
Dec 31, 2021 14.10 Mn